Related by context. All words. (Click for frequent words.) 68 Facet stockholders 67 International Rectifier stockholders 63 materially undervalues 63 Data Domain stockholders 63 Symyx stockholders 63 Mineralogy partial 62 Gold Kist stockholders 62 Adastra shareholders 62 Virtek shareholders 61 AXA APH minority 60 Engelhard stockholders 59 MathStar stockholders 59 iBasis stockholders 59 Caremark stockholders 59 Certara 58 Avigen stockholders 58 CF Industries stockholders 58 Friendly LRL 58 Enerflex unitholders 58 MCI shareowners 58 Chairman Tony Frankham 57 AMEX AOM 57 Certara Vector 57 Neurogen stockholders 57 fundamentally undervalues 57 Freewest shareholders 57 Zareba shareholders 57 Facet Biotech 57 Valeant unsolicited 56 Jien Offers 56 Revised Offer 56 Umbrellastream 56 Caremark shareholders 56 Cell Genesys stockholders 56 ESML Intressenter 56 eXegenics 56 VaxGen stockholders 56 Dioro shareholders 56 Aventis supervisory 56 Facet 56 SouthWest Water stockholders 56 Facet Biotech Corporation 56 NeuroMedix 56 Klondex shareholders 55 Liquor Barn unitholders 55 Trubion Pharmaceuticals TRBN 55 Kinbauri shareholders 55 MRL Offers 55 Airgas stockholders 55 stockholders 55 GPT unitholders 55 Bruandwo 55 Thoma Bravo Merger 55 Nio Metals 55 Noront Offer 55 Trubion Pharma 55 Valeant Pharma 55 Equigold shareholders 55 significantly undervalues NRG 55 Anormed 55 Faheem Hasnain 54 proposal significantly undervalues 54 On2 stockholders 54 Praecis 54 grossly undervalues 54 acquire Medafor 54 Sunov 54 Trintech Shareholders 54 Dynegy stockholders 54 Stelmar shareholders 54 Express Scripts Caremark 54 Conexant stockholders 54 Rusoro Offer 54 shares issuable pursuant 54 Silvercorp Offer 54 Lundin Transaction 53 Corporation NASDAQ GENZ 53 Mangrove Partners 53 opportunistically timed 53 Hexion Proposal 53 CPEX stockholders 53 Thermadyne shareholders 53 accompanying Explanatory Memorandum 53 Pala Partial Offer 53 please visit www.cpexpharm.com 53 AZD Offer 53 flatly rejected BHP 53 Cephalon NASDAQ CEPH 53 IsoTis stockholders 53 ArPetrol Transaction 53 Corp. NASDAQ GENZ 53 ARMZ Offer 53 JSE RDI OTCBB RDIAF 53 shareholders 53 ESML Intressenter AB 53 SumTotal stockholders 53 Biogen 53 #/shr 53 Adjournment Proposal 53 Cytopia 53 Solectron stockholders 53 Proposed Takeover 53 Pharmagesic 53 Invecture 53 Tornante MDP transaction 53 Pikra Vena 53 HealthCor 53 Jolina Proposal 53 EP MedSystems shareholders 53 AnorMed 53 significantly undervalues 52 TRACON Pharmaceuticals 52 IG HCR ;) CO 52 maximizing stockholder 52 SaskPool 52 Laddcap 52 Exelixis compounds 52 Appaloosa Cerberus 52 Shortlisted bidders 52 Revised Proposal 52 Preferred Stockholders 52 Phusion Laboratories 52 Corporation GENZ GENZ 52 Nasdaq ENZN 52 SPJSF 52 Contingent Value Rights 52 Superior Proposal 52 Jurong Cement 52 Transkaryotic 52 Alnara 52 Pessina KKR 52 Adventrx 52 Ribapharm 52 Nasdaq OMX ICE 52 Tornante MDP 52 Inc. NASDAQ XNPT 52 BIIB BIIB 52 Medafor shareholders 52 Sangaredi Refinery Project 52 DTLL 52 Laurent Condomine 52 LSRI Holdings 52 PharmaBio 52 CHLP 52 Dyax phage display 52 Simon Farallon 52 Arana Therapeutics Limited 52 Minimum Condition 52 insiders recused 52 Aeroflex stockholders 52 Jerini AG 52 debentureholders 52 Biovail Melnyk 52 Ception 52 Zenyth 52 LogicVision stockholders 52 Diedrich Coffee stockholders 52 substantially undervalues 52 Beckman Coulter BEC 52 Nasdaq BSTE 52 Verwilst repeated 52 Ensource 52 acquiror 52 CDP# 52 GrowthWorks Proposal 52 VMSI 52 NETM 52 Directors Unanimously Rejects 52 Inc. NASDAQ IDMI 52 Nasdaq BIIB 51 OSIP 51 Plavix patent 51 Steven Burakoff 51 Metabasis stockholders 51 Zenotech 51 offer substantially undervalues 51 Targanta 51 recission offer 51 MBRX 51 Nasdaq VRTX 51 Rule #a 8 51 William H. Rastetter 51 Xcyte 51 DPX Survivac 51 Chairman Yves Fortier 51 Novacea stockholders 51 OncoGenex Technologies 51 elbion NV 51 Trubion 51 Bioenvision 51 Corporation GENZ 51 CreXus 51 NASDAQ GNTA 51 Abbott Trilipix 51 Biopharm Development 51 Vernakalant 51 Indicative Proposal 51 Corautus 51 ComWest 51 convertible noteholders 51 Alan Santini 51 generic Copaxone 51 ADSs tendered 51 Cellu Tissue stockholders 51 Pluspetrol Offer 51 AnorMED 51 Trubion Pharmaceuticals 51 Biogen Idec 51 SUAI 51 Clarient CLRT 51 CRHI 51 NASDAQ ENZN 51 Unsolicited Proposal From 51 USPoly 51 SUAI stockholders 51 Penwest Pharmaceuticals Co 51 Trubion stockholders 51 Acorda Therapeutics Nasdaq ACOR 51 Galtstock.com 51 Contingent Value Right 51 Petaquilla Copper 51 NASDAQ Listing Qualification 51 Intelident 51 Chief Executive Henri Termeer 51 Cytopia shareholders 51 ENZN 51 Khanjee 51 NASDAQ IMCL 51 Obrem 51 Co BMY.N 51 minimally dilutive 51 CLDA 51 Minimum Tender 51 EvoGenix 51 Targacept TRGT 51 TLCR 51 Amended Cosmos Offer 51 LibiGel NDA 51 BHP Billiton hostile takeover 51 BTG plc 51 Durata Therapeutics 51 Reorganization Proposal 51 Rhein Biotech NV 51 significantly undervalues BEA 51 Xinlay 51 AUX Offer 51 Corp. Nasdaq TLCR 51 CEO Arthur Shorin 51 Cadbury plc 51 ACLARA 51 IPN Shareholders 51 Casey Nasdaq CASY 51 Greg Brostowicz spokesman 51 substantially undervalue 51 Tikcro 51 Retek stockholders 51 chairman Tony Frankham 51 Wellco unitholders 51 Rep Uno 51 CV Therapeutics 51 Icahn slate 51 Illumigen 51 Enzon Pharmaceuticals Inc 51 Dividend Reinvestment Plan DRIP 51 Micro Therapeutics 51 YS Mining 51 VentiRx 51 IntraBiotics 51 grossly undervalue 51 Genentech Roche 51 TheSUBWAY intends 51 FermaVir 50 OGeS 50 Adentri 50 BB BIOTECH 50 Dynepo TM 50 Genzyme Sanofi 50 dacetuzumab collaboration 50 NASDAQ BIIB 50 Rights Offering Circular 50 Vicuron Pharmaceuticals 50 NYSE ALJ Alon 50 Leo Tutt 50 Irrevocable undertakings 50 Medigen 50 Renovis stockholders 50 GPNL 50 staunchly opposed Kraft 50 Unitholder Rights 50 ISS RiskMetrics 50 Rautaruukki Oyj Rautaruukki 50 Genzyme Nasdaq GENZ 50 Inflazyme 50 CommScope stockholders 50 Inc. NASDAQ HGSI 50 Paladin Labs 50 TriPath 50 SynthRx 50 Biogen Idec Inc 50 EPE unitholders 50 NYSE Amex PTN 50 Naglazyme R 50 PRAECIS 50 Inc. NASDAQ CVTX 50 Nasdaq LTXC 50 Dr. Raafat Fahim 50 Revotar 50 IAMGold shareholders 50 ImClone Systems Inc IMCL.O 50 CIP TRAMADOL ER 50 Dr. Manuso 50 BLA filing 50 Tego Biosciences 50 DDJET 50 Janssen AI 50 Inc. Nasdaq DSCO 50 Avigen 50 Salmedix 50 proposal substantially undervalues 50 NewAlliance stockholders 50 Complete Response letter 50 contingently issuable shares 50 #p/share [001] 50 Aryx Therapeutics 50 Amylin Pharma 50 BIOCEUTICALS 50 BGH GP Holdings 50 NYSE FAL 50 VAALCO stockholders 50 Nasdaq Hearings Panel 50 BZ Acquisition 50 Alkermes plc 50 BID CANCELLATIONS 50 Inc. NASDAQ CEPH 50 ProUroCare 50 Genzyme Corp 50 RWCI 50 Aaron Brody Esq 50 Dr. Feczko 50 Eric Ende 50 Sparlon 50 Acorda Therapeutics NASDAQ ACOR 50 SILENOR 50 NASDAQ IPXL today 50 mutually satisfactory definitive 50 Ariva BDL TM 50 RBoS consortium 50 BcMetals 50 Advanced Analogic 50 Sunesis Pharmaceuticals 50 antibody humanization royalty 50 MyVax 50 Dr. Shrotriya 50 TriNet Notes 50 Energees Management 50 Psivida 50 Intelek Shareholders 50 underwriters overallotment option 50 maximize stockholder 50 TSX EQN ASX EQN 50 PIX# trial 50 HCA refiles 50 Inc XNPT 50 Fool contributor Tom Taulli 50 Inc MEDX 50 NASDAQ MEDI 50 commercialize SGN 50 Axa APH 50 Oncothyreon Inc 50 ARQL 50 NASDAQ CPEX 50 MYRX 50 BEA Systems Inc BEAS.O 50 Ramelius Offer 50 Nucryst 50 Chairman Rick Allert 50 CNPCI 50 Co BMY 50 WILEX 50 MedImmune MEDI 50 #.#B buyout 50 Sonja Rudd 50 Prima BioMed 50 Nasdaq NPSP 50 Nasdaq ASYT 50 website www.nyandcompany.com 50 Adnectin 50 PDLI 50 MPAM Wireless 50 NASDAQ Hearings Panel 50 Transkaryotic Therapies TKTX 50 Neosil 50 Junovan 50 GPMT 50 ONI BioPharma Inc. 50 Petrojarl 50 Aurox shareholders 50 CNX Gas Corp 50 Biologic License Application BLA 50 Biogen Nasdaq BIIB 50 ZIOPHARM Oncology 50 Cyclacel Pharmaceuticals 50 lumiliximab 50 lorcaserin NDA 49 ThyroTest R 49 Syntonix 49 Lundin Inmet 49 NeighborCare 49 NYSE Rule #A.# 49 NASDAQ FACT 49 nasdaq BIIB news 49 MELA Sciences NASDAQ MELA 49 Jean Jacques Bienaime 49 Dioro 49 Canvaxin 49 CHIR 49 Nasdaq IDRA 49 HepeX B 49 Accuray ARAY 49 CRG intends 49 anidulafungin 49 non waivable 49 Certara Corporation 49 Apex Bioventures 49 Printcafe 49 ADVENTRX 49 Tepnel 49 Inc. Nasdaq TRCA 49 Greenshoe option 49 Mr. Perlegos 49 Billionaire investor Icahn 49 unmarketable parcels 49 Michael Fonstein Ph.D. 49 ABII 49 Ocrelizumab 49 ViroChem Pharma Inc. 49 ENZON 49 FoxHollow stockholders 49 Del Monte DLM 49 Ramius nominees 49 Meda STO MEDAA 49 Wimar Tahoe 49 CeNeS 49 Complete Liquidation 49 WHC Proposal 49 Amended Offer 49 Progen 49 Inc. Nasdaq CVTX 49 optionholders 49 Tessco 49 PLLL Holdings LLC 49 Dr. Scangos 49 Bairnco 49 unexercised warrants 49 Arrangement Resolution 49 outstanding Restricted Voting 49 Montaur 49 TNF inhibitor therapy 49 motavizumab 49 Nasdaq MGRM 49 BMCA 49 Genelabs 49 Xenoport 49 PDL BioPharma Nasdaq PDLI 49 SupplySMART ™ energy 49 Biglari Holdings 49 Asentar 49 CYTR 49 Fortsum 49 Mr. Katotakis 49 Teva ADRs 49 Perlegoses 49 Senior Subordinated Noteholders 49 OSI Pharma 49 Penmont 49 HuLuc# 49 AHC Bid 49 Linjeta 49 NYSE PXP PXP 49 PDL BioPharma 49 Ariad Pharmaceuticals ARIA 49 Ferrovial consortium 49 Investor Relations section investor.biogenidec.comLiveTV LLC 49 FDA approvable letter 49 Insmed Incorporated NASDAQ INSM 49 Merged Entity 49 ticker CLAVIS 49 Inc OSIP 49 Furiex Pharmaceuticals 49 Nasdaq INHX 49 Fool contributor Jeremy MacNealy 49 Formation JER 49 golden parachute arrangements 49 disapplication 49 Onex Entities 49 NYSE TSX BVF 49 Javelin Pharmaceuticals 49 Electro Scientific 49 Fresbal 49 NRDC Acquisition 49 Mergence Corporation 49 OQI 49 Goran Ando 49 Enzon Pharmaceuticals Inc. 49 Eyetech Pharmaceuticals Inc. 49 NightHawk stockholders 49 WMI reorganization 49 CoTherix 49 rPA vaccine candidate 49 Pharmachem Revised Offer 49 AIM SLN Silence 49 Triarc Companies 49 Enpath ability 49 Daiichi Ranbaxy 49 AFCV 49 Eurand NV EURX 49 Wolf Haldenstein Investigates 49 ViewPoint MHC 49 CoGenesys 49 CreXus Investment Corp. 49 Vanda Pharma 49 adopting SFAS #R 49 please visit www.medicinova.com 49 Mr. Mihaylo 49 Curagen 49 Lundin Nominees 49 Celeritek 49 NASDAQ ARIA 49 Edam Acquisition 49 securityholders 49 Pink Sheets TAROF 49 Avalonbay 49 Atrium Biotechnologies 49 Corp. GENZ 49 Chesstown 49 Genzyme GENZ 49 Laura Brege 49 Solzira 49 Oremex Gold 49 AMEX PLX 49 Medicis Inamed 49 WEST CENTRAL Soil moisture 49 #p/shr 49 TorreyPines Therapeutics 49 Nasdaq AMLN 49 Mr. Karkus 49 Proposed Transactions 49 Energees 49 JLL Patheon Holdings 49 NASDAQ ABII 49 Inc. Nasdaq NSTK 49 Advises Stockholders 49 ashare 49 Regeneron Pharma 49 BioPhausia 49 opportunistically repurchase 49 NYSE Amex SNG 49 Mr. Bentsur 49 iloperidone 49 Oriole Partnership 49 Digimarc stockholders 49 GasNet 49 Virtek Position 49 NASDAQ NOVN 49 Terrenex 49 Cephalon 49 Geomark 49 dissident slate 49 ProLogis Declares Dividends 49 NYSE BRL 49 HDNG 49 Virbac SA 49 Tolmar 49 NASDAQ ALTH 49 Azimuth Opportunity 49 Somanta 49 Warner Chilcott plc 49 Mylan Labs 49 Kt Corp 49 Plan Permitted Bid 49 Aloprim 49 About DonHarrold.net DonHarrold.net 49 Chief Executive Bernard Poussot 49 AuthenTec stockholders 49 successfully commercialize Iluvien 49 Inc. NASDAQ MLNM 49 TLR9 agonists 49 Anaconda Offer 49 Inc. NASDAQ NOVC 49 Vicuron 49 Special Stockholder Meeting 49 Affected Creditors 49 SYGNIS 49 Nasdaq CHRW 49 Cenovus Energy CVE 49 Malloth appeal 49 massively undervalues 48 KKR Pessina 48 CEO Oleg Khaykin 48 Cambridge Antibody 48 Co BMY.N 行情 48 Mapa Spontex Baby 48 Oxigene 48 modestly dilutive 48 NeoResins 48 Unsolicited Proposal 48 CEFF financings subject 48 NASDAQ PGNX 48 requisite stockholder 48 frivolous Mulrain 48 Offeror intends 48 Raven biotechnologies inc 48 Investus Real Estate 48 CORLUX CORT # 48 TSX BVF 48 Axonyx 48 NASDAQ DNEX 48 NYSE CMX 48 VXGN 48 Nasdaq RXII 48 Inc. Nasdaq NEOL 48 Scrip Dividend Scheme 48 Encysive 48 Gastrotech 48 Circumpacific 48 Innogenetics 48 MethyPatch 48 Mr. Mitarotonda 48 WaveLight AG 48 International NYSE VRX 48 Aspreva 48 TSX AOM 48 Les Crudele president 48 Biogen Idec BIIB 48 Cyries 48 Intertech Bio 48 NASDAQ TGEN 48 SGXP 48 British confectioner 48 shareholders REJECT 48 PhosLo 48 PRNewswire FirstCall Monogram Biosciences 48 HGCH 48 Chugai Pharmaceutical Japan 48 Inc. Nasdaq SLXA 48 ValueAct 48 Co LLY.N 48 Fablyn 48 HSR clearance 48 Plicera 48 danoprevir 48 Nasdaq Delisting Notification 48 TOCOSOL Paclitaxel 48 significantly undervalue 48 significantly undervalues Airgas 48 dilutive issuances 48 OmegaCorp 48 Nasdaq SKYE 48 Webelieve 48 FDA Complete Response 48 Symphony GenIsis 48 AB OMXS BINV 48 OGE Enogex Partners LP 48 IVGN 48 Bionutrics 48 Synt em 48 Corporation NYSE CLW 48 Fool contributor Anders Bylund 48 accelerated renounceable entitlement 48 Nasdaq MAPP 48 Inc. Nasdaq EXEL 48 NOVC 48 Shire NASDAQ SHPGY 48 Omrix 48 CHOML 48 XNPT 48 ticker symbol BAH 48 Debenture Holders 48 TWYNSTA ® 48 NYSE AMEX PLX 48 Inc. NASDAQ EXEL 48 CCR5 receptor antagonist 48 Cytolin R 48 equityholders 48 Lupuzor 48 Permitted Bids 48 commonstock 48 Current Merger Agreement 48 NASDAQ FLML 48 FMMH 48 OSI Geospatial Inc 48 Inc MLNM 48 Optimal Acquisition 48 Willowstar 48 PRAECIS PHARMACEUTICALS INCORPORATED 48 repurchase authorizations 48 AMEX TGB Taseko 48 NPH Funds 48 Offer Consideration 48 rStar 48 Miikana Therapeutics 48 Delavaco Energy 48 RSDB shareholders 48 ZCI Offer 48 nondividend distribution 48 CombinatoRx Incorporated 48 buyback authorizations 48 Concerned Shareholder nominees 48 CanWest Petroleum 48 QuaTech 48 Biolipox 48 securityholder approval 48 FrontFour 48 #/share [001] 48 Proxy Circular 48 Nasdaq SVNT 48 Chairman Colm Barrington 48 Protalix BioTherapeutics 48 Nasdaq DVAX 48 AERx iDMS 48 CapLease 48 Mylan Laboratories MYL 48 Inc. Nasdaq SEPR 48 ReAble 48 wordt gedaan 48 Norsemont Shares 48 TSX VENTURE TTR 48 SangStat 48 Gralise 48 SMD Strategic 48 Incentive Compensation Plan 48 Merger Proposal 48 Deerfield Triarc 48 Criticare stockholders 48 Hearings Panel 48 Ariad Pharma 48 Valeant 48 Agco Corp AGJ.BE 48 Perpetual PIERS 48 CVTX 48 Herley Industries Inc HRLY 48 remaining untendered 48 telluridenews.com 48 generic Lovenox 48 Prime Standard PA8 48 Idenix Pharmaceuticals Inc 48 NASDAQ NPSP 48 ADSs validly tendered 48 NASDAQ DYAX 48 Ariad Pharmaceuticals 48 WellPoint NextRx subsidiaries 48 Abraxis Bioscience 48 adopts poison pill 48 Recapitalization Agreement 48 Corporation Nasdaq CHIR 48 NRDC Acquisition stockholders 48 Amicas 48 AKZO NOBEL 48 reorganized Solutia 48 supplemental biologics 48 Tolerx 48 Targanta Therapeutics Corporation 48 RX ACCULINK 48 IMC #B 48 KRONOS WORLDWIDE 48 HealthAxis 48 Lonza Proposal 48 Jesse Blout San Francisco 48 ISPH 48 Symphony Icon 48 NASDAQ INGN 48 wholly unconditional 48 Protherics PLC 48 Takeover Proposal 48 Plazacorp announces 48 Toctino ® alitretinoin 48 Inc. Nasdaq MYL 48 Nortel MEN 48 Octreolin 48 Aerogen 48 Alnara Pharmaceuticals 48 Inc. Nasdaq MEDX 48 Horizant 48 Corp. Nasdaq GENZ 48 Biogen Idec NASDAQ BIIB 48 Transkaryotic Therapies Inc. 48 BCY 48 NYSE MIM MID 48 Minemakers Offer 48 NeuroSolutions 48 atlanticnewstelegraph.com 48 NASDAQ AMAG 48 Hakon Invest 48 Cabilly patent 48 BGH unitholders 48 Fanapt 48 Firstmerit Corp FMER 48 Goldner Hawn 48 Corporate Governance Guidelines 48 ABGX 48 Nasdaq EPCT 48 Amended Merger Agreement 48 Incara 48 Calipso Offer 48 Lexicon Pharmaceuticals 48 Genzyme Corp GENZ.O 48 blood thinner prasugrel 48 dramatically undervalues 48 Extraordinary Dividend 48 TSX VENTURE CWM 48 Dendreon Nasdaq DNDN 48 CallWave stockholders 48 TSX VENTURE ADI 48 Valcon Acquisition BV 48 Skanditek 48 Tactical Armored 48 X Ceptor 48 Eric Donsky 48 NASDAQ EVCI 48 MedEmerg 48 DeWyze raspy tone 48 Board Unanimously Rejects 48 Inc. NASDAQ ACUS 48 Palisair 48 Biogen Idec Nasdaq BIIB 48 spokeswoman Laura Hortas 48 Ziopharm 48 CRGP intends 48 Nasdaq ISIS 48 TRBN 48 Biotie 48 Crexus 48 Nasdaq IMGN 48 PLLL Acquisition Co. 48 Inc. Nasdaq CKXE 48 Nasdaq CBST 48 AirTrust 48 Robertson Ceco 48 Elitech 48 CEO Ronald Dollens 48 Rezonic 48 Minimum Tender Condition 48 CeNeS Pharmaceuticals plc 48 tafamidis 48 Ligand Pharmaceuticals Incorporated 48 Vaccinex 48 Vistior 48 Alpharma ALO 47 collectively Ramius 47 Swedish Orphan Biovitrum 47 Proprius Pharmaceuticals 47 Nasdaq MAXM SSE MAXM 47 faropenem 47 AlintaGas 47 BioSource 47 NatFoods 47 Inc. Nasdaq HGSI 47 NRGP unitholders 47 Cubist Pharma 47 DDUP 47 novel MetAP 2 47 Inc. Nasdaq MLNM 47 Curidium 47 ARYx 47 Barington Companies 47 Immunogen 47 Abbott ABT 47 Privatebancorp Inc PVTB 47 website www.novavax.com 47 Dicer Substrate Technology 47 Epiphany Biosciences 47 TSX IEX 47 Zenotech Laboratories 47 UKCPT 47 Goldking 47 TSX VENTURE CPQ 47 AGA Medical stockholders 47 Zonagen 47 IFRS changeover 47 Maple Merger Sub 47 Celgene Corp CELG 47 thetransaction 47 TLCV 47 CC Finco 47 Competitor Report 47 Caprion 47 Nasdaq MYL 47 MicroCoal 47 Genzyme NASDAQ GENZ 47 TKT 47 Ampio 47 Tocosol Paclitaxel 47 Exelixis 47 Ligand Pharma 47 Allergan NYSE AGN 47 Zenpep 47 DTR #.#.#R 47 Universal Compression Partners LP 47 ImClone Systems Incorporated 47 Bel Fuse 47 BIGP 47 CureTech 47 VNDA 47 Montec Holdings 47 Inc. Nasdaq NVAX 47 Neose Technologies 47 EGI Acquisition LLC 47 Vertex VRTX 47 CEMATRIX 47 PGHI 47 Celldex 47 Nabi HB Intravenous 47 Poniard 47 Keith Katkin 47 DOV Pharmaceuticals 47 symbol SWY 47 Schedule #N 47 Sanctura XR 47 TechTeam Global stockholders 47 Auxilium Pharma 47 Unsolicited Tender Offer 47 leveraged recapitalization 47 Cell Pathways 47 coronary stent merged 47 Jeffrey Buchalter 47 proprietary Capillary Aerosolization Technology 47 Bristile 47 Cerberus ABP Investor 47 symbol GAM Pr 47 Seriatim 47 ZILG 47 IAAF Magyar 47 Nile Therapeutics 47 Nasdaq IDIX 47 Cadbury CBY 47 apricitabine ATC 47 DRAXIS 47 website www.VectorGroupLtd.com 47 Scheme Consideration 47 NYSE TRA 47 PRNewswire FirstCall Genta Incorporated 47 Bonus Warrants 47 approvable letters 47 ESIO 47 Stockholder Rights Agreement 47 NASDAQ REGN 47 Pallinghurst consortium 47 Dynepo 47 Myriad Pharmaceuticals 47 Proteostasis 47 Wintraysan 47 Proximagen 47 Contingent Convertible Senior 47 ARCA biopharma 47 CapGen Offering 47 Valentis 47 Crisa acquisition 47 NOVUS GOLD CORP. 47 apocalyptic aura 47 Transition Therapeutics 47 SILENOR ™ 47 GENZ 47 validly tendered pursuant 47 KWG Spider 47 Graniz Loan 47 Leezamax 47 Mr Buttula 47 Fording unitholders 47 TBNK 47 Inc. NASDAQ EVVV 47 TSX VENTURE PEF 47 ABX EGF 47 Irrevocable Undertakings 47 Protalix 47 ANDA submission 47 LTX Credence 47 BioDelivery Sciences 47 Movetis 47 Subsequent Offering 47 NASDAQ Listing Rules 47 ARYx Therapeutics Inc. 47 Ligand 47 Inspire Pharma 47 optionholder 47 SUTENT ® 47 Q4 Profit Decreases 47 InBev unsolicited 47 Biological License Application 47 Riskmetrics 47 MET amplification 47 Infor expressly disclaims 47 Celltech 47 Nasdaq TRCA 47 Carlsberg Heineken consortium 47 NASDAQ CYPB 47 EPCTD 47 PeriCor 47 XenoPort NASDAQ XNPT 47 MFG Offer